Navigation Links
US Senate Approves Embryo-research Plan Despite President's Refusal

The US Senate voted to expand federal funding for research on new human embryonic stem cells, setting the stage for George W. Bush's first veto of his presidency.//

The 63-37 vote followed two days of debate that pitted the promise of new disease cures against deep questions of conscience, especially among Bush's supporters on the religious right who view embryos as human life and oppose the measure.

Tuesday's vote was coloured by election-year politics and personal views that cut across party lines. The House of Representatives - Republican-controlled, like the Senate - had passed the bill last year.

White House spokesman Tony Snow reiterated before the vote that Bush would veto the measure.

"The president believes strongly that for the purpose of research it's inappropriate for the federal government to finance something that many people consider murder. He's one of them," Snow said.

The measure would lift restrictions Bush imposed in August 2001 on the grounds that the research destroys human embryos.

Scientists, eager to explore the potential for treating brain diseases such as Alzheimer's and diabetes, have pressed the government to ease the restrictions.

So has Senate Republican majority leader Bill Frist, a key White House ally in Congress who broke with Bush over stem-cell research last year.

Others who appealed to Bush to change his mind included former first lady Nancy Reagan, whose late husband Ronald Reagan suffered from Alzheimer's, and California Governor Arnold Schwarzenegger.

Frist, a medical doctor, argued Monday that the limitations will "slow our ability to bring potential new treatments for certain diseases."

Bush in 2001 limited federal research to 78 stem-cell lines derived from fertilized human eggs. Creating new lines would have involved the destruction of human embryos.

The government has since admitted that man y of the cell lines are contaminated, cutting the useable number to 22.

With polls showing most Americans support stem-cell research, opposition Democrats are seeking to capitalise on the issue in campaigning for mid-term Congressional elections in November.

But it appears unlikely that the 100-member Senate would muster the needed 67 votes to override a presidential veto.

(Source: IANS)
'"/>




Related medicine news :

1. Senate assures ban on smoking
2. US Senate Votes against Testing of Pesticide on Humans
3. Senate Committee Approves Telemedicine Mental Health Bill
4. US Senate Passes Stem Cell Research Bill
5. FDA Approves Contraceptive Ring
6. FDA Approves New HIV Drug, Viread
7. FDA Approves Birth Control Skin Patch
8. FDA Approves New Arthritis Drug, Bextra
9. FDA Approves Elidel Cream for Eczema
10. FDA Approves New Anti-Clotting Drug
11. FDA Approves New surgery Treatment for Farsightedness
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:6/27/2016)... ... June 27, 2016 , ... TherapySites, ... its affiliation with Tennessee Counseling Association. This new relationship allows TherapySites ... Tennessee Counseling Association, adding exclusive benefits and promotional offers. , "TCA is extremely ...
(Date:6/26/2016)... ... , ... Quality metrics are proliferating in cancer care, and are derived from ... of the beholder, according to experts who offered insights and commentary in the current ... For the full issue, click here . , For the American Society of ...
(Date:6/26/2016)... ... ... a legally blind and certified personal trainer is helping to develop a weight loss fitness ... to fix the two major problems leading the fitness industry today:, , ... They don’t eliminate all the reasons people quit their exercise program ...
(Date:6/25/2016)... ... ... The temporary closing of Bruton Memorial Library on June 21 due to a possible lice ... overlooked aspect of head lice: the parasite’s ability to live away from a human host, ... a necessary one in the event that lice have simply gotten out of control. , ...
(Date:6/25/2016)... , ... June 25, 2016 , ... ... and non-athletes recover from injury. Recently, he has implemented orthobiologic procedures as a ... area —Johnson is one of the first doctors to perform the treatment. Orthobiologics ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)... CHAPEL HILL, N.C. , June 24, 2016 ... in healthcare decisions and regulators/payers have placed more ... this new environment, patient support programs in the ... support for patients, medications. Consequently, pharmaceutical companies are ... to ensure they are providing products and services ...
(Date:6/24/2016)... 24, 2016  Global Blood Therapeutics, Inc. (GBT) (NASDAQ: ... novel therapeutics for the treatment of grievous blood-based ... closing of its previously announced underwritten public offering ... public offering price of $18.75 per share. All ... by GBT. GBT estimates net proceeds from the ...
(Date:6/24/2016)... , June 24, 2016 ... Markets has announced the addition of the " ... offering. This ... and provides an updated review, including its applications in ... the total market, which includes three main industries: pharmaceutical ...
Breaking Medicine Technology: